home / stock / cnta / cnta articles

CNTA Articles, Centessa Pharmaceuticals plc

Stock Information
Company Name: Centessa Pharmaceuticals plc
Stock Symbol: CNTA
Market: NASDAQ
Website: centessa.com
Menu
CNTA CNTA Quote CNTA Short CNTA News CNTA Articles CNTA Message Board
Get CNTA Alerts

News, Short Squeeze, Breakout and More Instantly...
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer | Benzinga

BOSTON and LONDON, June 10, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that a...
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares | Benzinga

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company tha...

Centessa Pharmaceuticals to Participate in TD Cowen's 44th Annual Health Care Conference | Benzinga

BOSTON and LONDON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that ai...

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Take-Two...
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply ...

Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at the 17th Annual Congress of the European Association for Haemophilia and

BOSTON & LONDON, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA) announced that data from an additional 52-week...

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences | Benzinga

BOSTON and LONDON, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that ai...
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recordi...

Centessa Pharmaceuticals Announces Additions to Senior Leadership Team | Benzinga

BOSTON and LONDON, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that ai...

Centessa Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference | Benzinga

BOSTON and LONDON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that a...
Next 10